Tuesday, January 3, 2017

Assessing drug-induced cardiotoxicity in vitro - Wed, 04/01/2017 - 05:15

[Source: JRC] In a collaborative effort, the JRC and three European partner organisations gathered lacking knowledge necessary to develop predictive in vitro tests that can identify the risk for the development of cumulative dose-dependent cardiotoxicity of cancer patients treated with anthracyclines.

from EUROPA - Syndicated Research News Feed http://ift.tt/2iGv2yj
via IFTTT

No comments:

Post a Comment